Background
CVS operates ~9,000 retail pharmacies. The in-store experience is consistently rated poorly; pharmacists are overworked; prescription pickup is friction-heavy. Mail-order and Mark Cuban's Cost Plus Drugs are siphoning script volume.
The disruption thesis
A direct-to-consumer pharmacy that uses telehealth + same-day delivery + transparent cash pricing can serve the 40% of Americans who pay out-of-pocket for at least one prescription.
⚠Why it's vulnerable
- 01Poor user experience
- 02High prices / margins
- 03Manual / labor-heavy workflow
🛡How they are defensible
No defensibility analysis yet.
⚔Emerging challengers
Startups and challengers trying to take share.
Curated entry · added May 17, 2026
Similar companies
- MMcKessonHealthcare · Public
Pharmaceutical distribution giant on thin margins and opaque supply chains, exposed to AI-driven logistics.
- CChange HealthcareHealthcare · Subsidiary
Concentrated healthcare-claims infrastructure exposed after a major outage, ripe for resilient, AI-native rivals.
- EEpic SystemsHealthcare · Private
Hospital EHR monopoly with painful UX and high TCO
Defense4/5 - EEviCore HealthcareHealthcare · Subsidiary
Prior-authorization manager criticized for slow, manual reviews, ripe for AI-driven, transparent utilization management.
- LLegacy Healthcare Staffing AgenciesHealthcare · Business category
Manual, fragmented healthcare staffing agencies exposed to digital marketplaces with automated credentialing and forecasting.
- OOracle Health / CernerHealthcare · Subsidiary
Legacy EHR with poor clinician usability and heavy documentation burden, ripe for AI-native replacement.